Page last updated: 2024-08-17

triamcinolone acetonide and Glaucoma, Neovascular

triamcinolone acetonide has been researched along with Glaucoma, Neovascular in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Degenring, RF; Jonas, JB; Kreissig, I1
Bonanomi, MT; Susanna, R1
Hayler, JK; Jonas, JB; Panda-Jonas, S; Söfker, A1

Trials

1 trial(s) available for triamcinolone acetonide and Glaucoma, Neovascular

ArticleYear
Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone.
    Journal of glaucoma, 2001, Volume: 10, Issue:4

    Topics: Aged; Aged, 80 and over; Crystallization; Diabetic Retinopathy; Female; Glaucoma, Neovascular; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris; Male; Middle Aged; Neovascularization, Pathologic; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body

2001

Other Studies

2 other study(ies) available for triamcinolone acetonide and Glaucoma, Neovascular

ArticleYear
Neovascular glaucoma treated by intravitreal triamcinolone acetonide.
    Acta ophthalmologica Scandinavica, 2003, Volume: 81, Issue:5

    Topics: Aged; Glaucoma, Neovascular; Glucocorticoids; Humans; Injections; Middle Aged; Triamcinolone Acetonide; Vitreous Body

2003
Intravitreal triamcinolone acetonide as adjunctive treatment for neovascular glaucoma.
    Clinics (Sao Paulo, Brazil), 2005, Volume: 60, Issue:4

    Topics: Aged; Anti-Inflammatory Agents; Female; Glaucoma, Neovascular; Humans; Injections; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body

2005